News

The Hawaii Department of Health has confirmed a travel-related case of Zika virus on Oahu — the first in the state in six ...
While multiple machine learning (ML) algorithms offered similar predictive performance, the cost-effective analysis revealed ...
FDA places clinical hold of RP-A501 for the treatment of patients with Danon disease due to a patient death. Click here to ...
DragonForce is a new-ish ransomware-as-a-service gang that gained notoriety in April after cybercrime “cartel” Scattered ...
Montana is home to the Rocky Mountain wood tick and the American dog tick, which can also spread diseases such as Rocky ...
Evolv Technologies has demonstrated SaaS-driven growth, robust ARR, expansion in education and healthcare, and a scalable ...
Scientists at the McGovern Institute for Brain Research at MIT and the Broad Institute of MIT and Harvard have re-engineered ...
The cost of cybercrime globally has been estimated at $10.5 trillion in 2025 — more per year than all natural disasters combined and generating more illegal profits than the global drug trade.
Rocket Pharmaceuticals acknowledged the death of a patient in a pivotal trial assessing its Danon disease gene therapy candidate RP-A501, a study that the FDA has placed on clinical hold.
CRANBURY, NJ, USA I May 27, 2025 I Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing an integrated ...
Preliminary findings released last July by the Commission found that X was in breach of the Digital Services Act, citing ...
First Legal, the nation's leading litigation support and attorney services firm, is pleased to announce the appointment of ...